Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-7
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Neonatal jaundice is a physiological process characterized by a yellow coloration of the skin and mucous membranes linked to an increase in a pigment: bilirubin. However, an excessive accumulation of bilirubin can lead to neurological complications: kernicterus. The screening for pathological jaundice is carried out through daily measurements of transcutaneous bilirubin using non-invasive devices (bilirubinometers). The diagnosis is made by measuring blood bilirubin levels and comparing them with reference curves. In newborns with dark skin, transcutaneous bilirubin measurements may be inaccurate because melanin interferes with the bilirubinometers.

Eligibility criteria

Qualifiers

Born from 36 weeks of amenorrhea

Hospitalized in the postnatal ward or kangaroo care unit

Requiring a blood test for bilirubin analysed at the Cochin laboratory.

No objection from both holders of parental authority.

Disqualifiers

Having received phototherapy treatment within the last 24 hours

Trial design

Treatments tested in this trial

  • Skin color assessment

Treatment groups

510 Participants
are divided into 1 treatment group

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator